Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 1/20 | 0.49 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.49 |
| ▸ | RPS6KB1 | P23443 | 11/20 | 0.41 |
| ▸ | SLC9A1 | P19634 | 5/20 | 0.36 |
| ▸ | SLC9A2 | Q9UBY0 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 7/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26629804 | 1.00 | QPCT (0.49) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 | |
| SCHEMBL30610990 | 0.91 | QPCT (0.50) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 | |
| SCHEMBL30610998 | 0.91 | QPCT (0.50) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 | |
| SCHEMBL26629815 | 0.91 | QPCT (0.50) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 | |
| SCHEMBL26750620 | 0.91 | QPCT (0.52) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 | |
| SCHEMBL26629803 | 0.91 | QPCT (0.50) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 | |
| SCHEMBL24377365 | 0.90 | QPCT (0.55) | QPCTQPCTLRPS6KB1AKT1PIK3CA | |
| SCHEMBL24377345 | 0.89 | QPCT (0.52) | QPCTQPCTLRPS6KB1SLC9A1AKT1 | |
| SCHEMBL30610999 | 0.88 | SLC9A1 (0.48) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 | |
| SCHEMBL26629809 | 0.88 | SLC9A1 (0.48) | QPCTQPCTLRPS6KB1SLC9A1SLC9A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023205173-A1 | SUBSTITUTED PIPERIDINES AND SUBSTITUTED TETRAHYDROPYRIDINES AS IMMUNE-MODULATING COMPOUNDS | BLACKSMITH MEDICINES, INC. (US) | 2023-10-26 | — | — | WO | disclosed |